Comparison of two modalities in the treatment of localised patchy hair loss - comparison of fractional CO2 laser with topical Bimatoprost 0.03% compared with fractional CO2 laser with topical Triamcinolone Acetonide

A comparative study of fractional CO2 laser with topical Bimatoprost 0.03% versus fractional CO2 laser with topical Triamcinolone Acetonide in the treatment of alopecia areata. - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/10/058243

Enrollment

Registered

2023-10-04

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L639- Alopecia areata, unspecified

Interventions

Intervention1: fractional co2 laser with topical bimatoprost 0.03%: 5 settings at interval of 3 weeks. In each setting 1ml Bimatoprost 0.03% will be applied after giving fractional CO2 laser to each p

Eligibility

Inclusion criteria

Inclusion criteria: Patients with localised Alopecia Areata over any part of the body

Exclusion criteria

Exclusion criteria: 1. Patients with other systemic illness - cardiac, renal, hepatic illness 2. Severely Immunocompromised 3. Pregnancy 4. Patients taking photosensitive drugs and photosensitivity 5. Patients 6. Patients not willing for study

Design outcomes

Primary

Measure	Time frame
Reduction in Lesional Area Density score Timepoint: Before each setting every 3 weeks	—

Secondary

Measure	Time frame
Adverse effects seen with Fractional CO2 Laser & Topical Triamcinolne and BimatoprostTimepoint: Before each setting - every 3 weeks	—

Countries

India

Contacts

Public ContactDr. Hussain Kolsawala

Sri Devaraj Urs Medical College,Tamaka, Kolar

kelojihan123@gmail.com9844232679

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026